期刊
PSYCHONEUROENDOCRINOLOGY
卷 48, 期 -, 页码 123-135出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.psyneuen.2014.06.005
关键词
Alzheimer's disease; Prediabetes; Hyperinsulinemia; Amyloid-beta; Tau; Microglia; Insulin degrading enzyme; Neprilysin; Haemorrhage
资金
- Ramon y Cajal program [RYC-2008-02333]
- ISCIII - Subdireccion General de Evaluacion y Fomento de la Investigacion
- Fondo Europeo de Desarrollo Regional Una manera de hacer Europa [PI12/00675]
Age remains the main risk factor for developing Alzheimer's disease (AD) although certain metabolic alterations, including prediabetes and hyperinsulinemia, also increase this risk. We present a mouse model of AD (APPswe/PS1dE9 mouse) with severe hyperinsulinemia induced by long-term high fat diet (HFD) treatment. After 23 weeks on HFD learning and memory processes were compromised. We observed a significant increase in tau hyperphosphorylation and A beta pathology, including A beta levels and amyloid burden. Microglia activation was also significantly increased in HFD-treated mice, both in close proximity to and far from senile plaques. Insulin degrading enzyme and neprilysin levels were not affected, suggesting that A beta degradation pathways were preserved, whereas we detected an increase in spontaneous cortical bleeding that could underlay an impairment of A beta interstitial fluid drainage, contributing to the increase in A beta deposition in APP/PS1-HFD mice. Altogether our data suggest that early hyperinsulinemia is enough to exacerbate AD pathology observed in APP/PS1 mice, and supports the role of insulin-resistance therapies to stop or delay central complications associated. (C) 2014 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据